Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research

Genomic epidemiology is a field of research that seeks to improve the prevention and management of common diseases through an understanding of their molecular origins. It involves studying thousands of individuals, often from different populations, with exacting techniques. The scale and complexity of such research has required the formation of research consortia. Members of these consortia need to agree on policies for managing shared resources and handling genetic data. Here we consider data-sharing and intellectual property policies for an international research consortium working on the genomic epidemiology of malaria. We outline specific guidelines governing how samples and data are transferred among its members; how results are released into the public domain; when to seek protection for intellectual property; and how intellectual property should be managed. We outline some pragmatic solutions founded on the basic principles of promoting innovation and access.

[1]  Ronald D. Brunner,et al.  Science and social responsibility , 1992 .

[2]  M. Olivier A haplotype map of the human genome , 2003, Nature.

[3]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[4]  M. Kremer,et al.  Perspectives on stimulating industrial research and development for neglected infectious diseases. , 2001, Bulletin of the World Health Organization.

[5]  Els Torreele,et al.  Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.

[6]  Solomon Nwaka,et al.  Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.

[7]  R. Eisenberg Patent Swords and Shields , 2003, Science.

[8]  Sammy Wambua,et al.  An Immune Basis for Malaria Protection by the Sickle Cell Trait , 2005, PLoS medicine.

[9]  B. Daviss Malaria, science, and social responsibility , 2005 .

[10]  S. K. Baniwal,et al.  Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein. , 2004, Vaccine.

[11]  A. Ashley-Koch,et al.  Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. , 2000, American journal of epidemiology.

[12]  G. McVean,et al.  Recombination Hotspots and Population Structure in Plasmodium falciparum , 2005, PLoS biology.

[13]  S. Salzberg,et al.  Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution , 2005, Nature.

[14]  O. Doumbo,et al.  Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria , 2005, Nature.

[15]  P A Singer,et al.  Grand Challenges in Global Health , 2003, Science.

[16]  L. Miller,et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.

[17]  S. Herrera,et al.  Plasmodium vivax malaria vaccine development. , 2001, Molecular immunology.

[18]  C. Chitnis,et al.  Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion , 1994, The Journal of experimental medicine.

[19]  Mary Moran,et al.  A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need , 2005, PLoS Medicine.

[20]  A. Olivieri,et al.  Haemoglobin C protects against clinical Plasmodium falciparum malaria , 2001, Nature.

[21]  Amy Kapczynski Addressing Global Health Inequities: An Open Licensing Approach for University Innovations , 2005 .